PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool

PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool

Blog Article

Summary: Drug development has been hampered by a high failure rate in clinical trials due to our incomplete understanding of drug functions across organs and species.Therefore, elucidating species- and tissue-specific drug functions can provide insights into therapeutic efficacy, potential adverse effects, and interspecies differences necessary for effective 2006 nissan altima radio translational medicine.Here, we present PharmOmics, a drug knowledgebase and analytical tool that is hosted on an interactive web server.

Using tissue- and species-specific transcriptome data from human, mouse, and rat curated from different databases, we implemented a gene-network-based approach for drug repositioning.We demonstrate the potential of PharmOmics to retrieve known therapeutic drugs and identify drugs with tissue toxicity using in silico performance assessment.We further validated predicted drugs for nonalcoholic burl audio b2 bomber adc fatty liver disease in mice.

By combining tissue- and species-specific in vivo drug signatures with gene networks, PharmOmics serves as a complementary tool to support drug characterization and network-based medicine.